Abstract
Purpose
Gold nanoparticles have been proved useful for many biomedical applications, specifically, for their use as advanced imaging systems. However, they usually present problems related with stability and toxicity.
Methods
In the present work, gold-nanoparticles have been encapsulated in polymeric nanoparticles using a novel methodology based on nano-emulsion templating. Firstly, gold nanoparticles have been transferred from water to ethyl acetate, a solvent classified as class III by the NIH guidelines (low toxic potential). Next, the formation of nano-emulsions loaded with gold nanoparticles has been performed using a low-energy, the phase inversion composition (PIC) emulsification method, followed by solvent evaporation giving rise to polymeric nanoparticles.
Results
Using this methodology, high concentrations of gold nanoparticles (>100 pM) have been encapsulated. Increasing gold nanoparticle concentration, nano-emulsion and nanoparticle sizes increase, resulting in a decrease on the stability. It is noteworthy that the designed nanoparticles did not produce cytotoxicity neither hemolysis at the required concentration.
Conclusions
Therefore, it can be concluded that a novel and very versatile methodology has been developed for the production of polymeric nanoparticles loaded with gold nanoparticles.
Similar content being viewed by others
Abbreviations
- AuNP:
-
Gold nanoparticles
- CTAB:
-
Cetyltrimethylammonium bromide
- DLS:
-
Dynamic light scattering
- NE(Au):
-
AuNP-loaded nano-emulsions
- NP(Au):
-
AuNP-loaded PLGA nanoparticles
- PIC:
-
Phase inversion composition method
- PLGA:
-
Poly(lactide-co-glycolic acid)
- RES:
-
Reticuloendothelial system
- TOAB:
-
Tetraoctylammonium bromide
References
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70(1–2):1–20.
Tadros TF, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci. 2004;108–109:303–18.
Pinto RC, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine. 2006;2(1):8–21.
Kreuter J. Nanoparticles as drug delivery systems, encyclopedia of nanoscience and nanotechnology, edited by Singh Nawla H. Am Sci Publ. 2004;7:161–80.
Couvreur P, Vauthier C. Nanotechnology: Intelligent design to treat complex diseases. Pharm Res. 2006;23(7):1417–50.
Mura S, Couvreur P. Nanotheranostics for personalized medicine. Adv Drug Del Rev. 2012;64:1394–416.
Klang Sh, Benita S. Design and evaluation of submicron emulsions as colloidal drug carriers for intravenous administration, Submicron emulsions in drug targeting and delivery, edited by Simon Benita. Ciutat. 1998;119–152.
Tamilvanan S. Oil-in-water lipid emulsions: Implications for parenteral and ocular delivering systems. Prog Lipid Res. 2004;43:489–533.
Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res. 2009;26(5):1025–58.
Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: Formulation insights, applications and advances. Nanomedicine. 2010;5(10):1595–616.
Neha B, Ganesh B, Preeti K. Drug delivery to the brain using polymeric nanoparticles: a review. Int J Pharm Life Sci. 2013;2(3):107–32.
Teixera Z, Dreiss CA, Lawrence M, Heenan RK, Mahcado D, Justo GZ, et al. Retinyl palmitate polymeric nanocapsules as carriers of bioactives. J Colloid Interface Sci. 2012;382:36–47.
Guterres SS, Alves MP, Pohlmann AR. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications, drug target insights. Libr Acad. 2007;2:147–57.
Gref R, Domb A, Quellec P, Blunk T, Müller RH, Verbavatz JM, et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev. 1995;64:316–26.
Cook RO, Pannu RK, Kellaway IW. Novel sustained release microspheres for pulmonary drug delivery. J Control Release. 2005;104(1):79–90.
Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;64:24–36.
Gupta MK, Prakash D, Mishra B. Biodegradable microparticulate drug delivery system of diltiazem HCl. Braz J Pharm Sci. 2012;48(4):699–709.
Hayat MA. Colloidal gold: principles, methods and applications. Academic Press, Inc.; 1989.
Salas G, Casado C, Teran FJ, Miranda R, Serna CJ, Puerto MM. Controlled synthesis of uniform magnetic nanocrystals with high-quality properties for biomedical applications. J Mater Chem. 2012;22:21065–75.
Jiang S, Eltoukhy AA, Love KT, Langer RE, Anderson DG. Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery. Nano Lett. 2013;13(3):1059–64.
Khlebtsov N, Dykmana L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev. 2011;40:1647–71.
Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: Recent advances and perspectives. Chem Soc Rev. 2012;41:2256–82.
Daniel MC, Astruc D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev. 2004;104(1):293–346.
Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev. 2009;38:1759–82.
Murphy CJ, Gole AM, Stone JW, Sisco PN, Alkilany AM, Goldsmith EC, et al. Gold nanoparticles in biology: Beyond toxicity to cellular imaging. Acc Chem Res. 2008;41(12):1721–30.
Watson KJ, Zhu J, Nguyen ST, Mirkin CA. Hybrid nanoparticles with block copolymer shell structures. J Am Chem Soc. 1999;121:462–3.
Solans C, Solè I. Nano-emulsions: Formation by low-energy methods. Curr Opin Colloid Interface Sci. 2012;17:246–54.
Fornaguera C, Dols-Perez A, Calderó G, García-Celma MJ, Camarasa J, Solans C. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier. J Control Release. 2015;211:134–43.
Cheng W, Wang E. Size-dependent phase transfer of gold nanoparticles from water into toluene by tetraoctylammonium cations: a wholly electrostatic Interaction. J Phys Chem B. 2004;108(1):24–6.
Joshi CP, Bigioni TP. Model for the phase transfer of nanoparticles using ionic surfactants. Langmuir. 2014;30(46):13837–43.
Fornaguera C, Grijalvo S, Galán M, Fuentes-Paniagua E, de la Mata FJ, Gómez R, et al. Novel non-viral gene delivery systems composed of carbosilane dendron functionalized nanoparticles prepared from nano-emulsions as non-viral carriers for antisense oligonucleotides. Int J Pharm. 2015;478(1):113–23.
Calderó G, García-Celma MJ, Solans C. Formation of polymeric nano-emulsions by a low-energy method and their use for nanoparticle preparation. J Colloid Interface Sci. 2011;353:406–11.
Underwood S, Mulvaney P. Effect of the solution refractive index on the color of gold colloids. Langmuir. 1994;10(10):3427–30.
Liz-Marzaán LM, Giersig M, Mulvaney P. Synthesis of nanosized gold-silica core-shell particles. Langmuir. 1996;12:4329–35.
Chen S, Yao H, Kimura K. Reversible transference of Au nanoparticles across the water and toluene interface: a langmuir type adsorption mechanism. Langmuir. 2001;17(3):733–9.
Fotakis G, Timbrell JA. In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to calcium chloride. Toxicol Lett. 2006;160:171–7.
Fendler JH Meldrum FC. The colloid chemical approach to nanostructured materials. Adv Mater. 1995;7(7):607–32.
Wretlind AJ. The pharmacological basis for the use of fat emulsions in intravenous nutrition. Acta Chir Scand Suppl. 1964;325:31–41.
Dobrovolskaia MA, McNeil S. Handbook of immunological properties of engineered nanomaterials, Frontiers in Nanobiomedical esearch, SAIC-Frederick, Inc.: USA; 2013.
Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: What do we know? Adv Drug Deliv Rev. 2014;71:2–14.
Fornaguera C, Caldero G, Solans C. Electrolytes as a tuning parameter to control nano-emulsion and nanoparticle size. RSC Adv. 2016;6:58203–11.
Anton N, Benoit JP, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release. 2008;128:185–99.
Frens G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature Phys Sci. 1973;241:20–2.
Lim ZJ, Li JJ, Ng CT, Yung LL, Bay BH. Gold nanoparticles in cancer therapy. Acta Pharmacol Sin. 2011;32:983–90. doi:10.1038/aps.2011.82. Published online 11 Jul 2011.
Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1(3):325–7.
Voigt N, Henrich-Noacl C, Kocckentiedt S, Hintz W, Tomas J, Sabel BA. Toxicity of polymeric nanoparticles in vivo and in vitro. J Nanopart Res. 2014;16:2379–92.
Dreaden EC, Alkilany AM, Huang X, Murphy CJ, El-Sayed MA. The golden age: Gold nanoparticles for biomedicine. Chem Soc Rev. 2012;41:2740–79.
Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. 5th ed. London: Pharmaceutical-Press; 2006.
Schärtl W. Light scattering from polymer solutions and nanoparticle dispersions, Springer laboratory, ed. Pasch H.; 2006p. 22. ISBN: 978-3-540-71951.
Delgado AV, González-Caballero F, Hunter RJ, Koopal LK. Measurement and interpretation of electrokinetic phenomena. J Colloid Interface Sci. 2007;309:194–224.
Putnam D, Gentry CA, Pack DW, Langer R. Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. PNAS. 2001;98(3):1200–5.
Hansen MB, Nielsen SG, Berk K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989;119(2):203–10.
Aparicio RM, García-Celma MJ, Vinardell MP, Mitjans M. In vitro studies of the hemolytic activity of microemulsions in human erythrocytes. J Pharm Biomed Anal. 2005;39:1063–7.
ACKNOWLEDGMENTS AND DISCLOSURES
Financial support from MINECO (grants CTQ2014-52687-C3-1-P and CTQ2016-80645-R); Generalitat de Catalunya (grant 2014-SGR-1655), and CIBER-BBN are acknowledged. CIBER-BBN is an initiative funded by the VI National R&D&I Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. Cristina Fornaguera is grateful to AGAUR for their Predoctoral Fellowship (grant FI-DGR 2012). Natàlia Feiner is grateful to CIBER-BBN for their Research Initiation Fellowship.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 196 kb)
Rights and permissions
About this article
Cite this article
Fornaguera, C., Feiner-Gracia, N., Dols-Perez, A. et al. Versatile Methodology to Encapsulate Gold Nanoparticles in PLGA Nanoparticles Obtained by Nano-Emulsion Templating. Pharm Res 34, 1093–1103 (2017). https://doi.org/10.1007/s11095-017-2119-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-017-2119-1